Hims & Hers Health Inc (NYSE:HIMS) shares traded -0.30% lower at $29.72 on Wall Street last session.
HIMS stock price is now 7.46% away from the 50-day moving average and 45.98% away from the 200-day moving average. The market capitalization of the company currently stands at $6.49B.
With the price target enhanced from $24 to $25, Citigroup Downgraded its rating from Neutral to Sell for Hims & Hers Health Inc (NYSE: HIMS). On January 07, 2025, BTIG Research recently initiated its ‘Buy’ rating on the stock quoting a target price of $35, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, Dudum Andrew, Officer bought 14,269 shares of the company’s stock on Jan 22 ’25. The stock was bought for $429,184 at an average price of $30.08. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 21 ’25, Officer Melissa Baird bought 67,687 shares of the business’s stock. A total of $2,017,749 was incurred on buying the stock at an average price of $29.81. A total of 18.77% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $8.44 and a high of $35.02. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82. The fifty day moving average price for HIMS is $27.5304 and a two-hundred day moving average price translates $20.2831 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-09-30. The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent.
